摘要
目的 探讨辛二酰苯胺异羟肟酸(SAHA)对人卵巢癌细胞恶性表型的作用及其可能的分子作用机制。方法(1)选取2组人卵巢癌细胞(SKOV3和SKOV3/DDP;HO8910和HO8910-PM)后,设置对照组和终浓度为1、3、5及7μmol/L SAHA组(SAHA 1~4组),采用CCK-8法分别检测SAHA对细胞增殖的影响。(2)设置对照组和SAHA 1、2组(2和5μmol/L),Annexin V-FITC/PI双标记流式细胞术分别检测SAHA对细胞凋亡及周期的影响。(3)RT-PCR和Western blot检测SAHA 1~4组表型相关蛋白的表达水平。结果 (1)随着SAHA浓度的增加,SKOV3细胞株SKOV3/DDP及HO8910细胞株48 h光密度(OD)值均呈逐渐降低趋势(均P〈0.05)。(2)48 h SAHA 1、SAHA 2组凋亡率高于对照组(均P〈0.05);SAHA作用48 h,细胞周期发生阻滞,与对照组比较,SAHA 1组和SAHA 2组SKOV3和SKOV3/DDP细胞S期和G2/M期比例增高,HO8910和HO8910-PM细胞G0/G1期比例增高(P〈0.05)。(3)SAHA 1、2组Cyclin B1和Cdc2(p34)的m RNA表达水平均低于对照组,Caspase-3、p21和p53的m RNA表达水平明显高于对照组(P〈0.05);SAHA 1~4组Ac-Histone H3和Ac-Histone H4和p53蛋白的表达较对照组明显增强,Cyclin B1、Cdc2(p34)蛋白的表达减弱。结论 SAHA通过调节恶性表型相关蛋白Caspase-3、p53、Cyclin B1和Cdc2(p34)的表达水平,促进组蛋白乙酰化,抑制卵巢癌细胞增殖,阻滞细胞周期并诱导细胞凋亡。
Objective To explore the effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on ovarian carcinoma. Methods (I) Two groups of ovarian carcinoma cell lines (SKOV3 and SKOV3/DDP, HO8910 and HO8910-PM) were exposed to SAHA (1, 3, 5 and 7 μmol/L SAHA, group 1-group 4). CCK-8 method was employed to evaluate the inhibitory effects of SAHA. (2)Ovarian cancer cell lines treated with SAHA (2 or 5 μmol/L SAHA) were used as 1 and 2 groups. Flow cytometry was performed following staining with Annexin V-FITC and PI for cell cycle and apoptosis. (3) Reverse transcription polymerase chain reaction (RT-PCR) and Western blot assay were used to assess the mRNA and protein expression levels of phenotypic correlation factor. Results ( 1 )After 48 h of SAHA treatment, the OD value of SKOV3, SKOV3/DDP, and HO8910 showed a trend of gradually reduce (P 〈 0.05). (2)The apoptotic rates were significantly higher in SAHA 1 and SAHA 2 groups than those of control group (P 〈 0.05). Compared with control group, after 48 h of SAHA treat- ment, S phase and G2/M phase of SKOV3 and SKOV3/DDP cells increased; G0/G1 phase of HO8910 and HO8910-PM cells increased in SAHA 1 and 2 groups (P 〈 0.05).(3)The expression levels of CyclinB1 and Cdc2 (p34) mRNA were significantly lower in SAHA 1 and 2 groups than those of control group, while the expression levels of Caspase-3, p21 and p53 mRNA expression were significantly higher in SAHA 1 and 2 groups than those of control group. Furthermore, the expression of Ac-Histone H3, Ac-Histone H4, p53 protein were markedly improved, and CyclinB 1, Cdc2(p34) protein decreased in SAHA 1- 4 groups. Conclusion SAHA may suppress cell growth, induce apoptosis and cause cycle arrest in ovarian carcinoma cells by promoting histone aeetylation or modulating their phenotype-related proteins of Caspase-3, p53, CyclinB 1 and Cdc2(p34).
出处
《天津医药》
CAS
2016年第2期149-154,I0003,共7页
Tianjin Medical Journal
基金
国家自然科学基金资助项目(81172371
81472544)
辽宁省科学技术计划项目(2005408001)
辽宁省教育厅优秀人才支持计划(LJQ2014093)
辽宁医学院校长基金项目(XZJJ2014020
XZJJ20140203)
关键词
卵巢肿瘤
细胞凋亡
细胞增殖
恶性表型
辛二酰苯胺异羟肟酸
组蛋白乙酰化
ovarian neoplasms
apoptosis
cell proliferation
malignant phenotype
suberoylanilide hydroxamic acid
histone acetylation